Immediately prior to the 10th Annual ICSA Meeting, we will co-host the SenoTherapeutics Summit in collaboration with the Phaedon Institute. Building upon the success of previous summits, this year's event aims to foster collaboration among key stakeholders to drive the development of therapies that promote healthy aging and longevity.
About the Summit
The Phaedon Senotherapeutic Summit serves as a premier platform for key opinion leaders in longevity science and therapeutic development, fostering a collaborative environment for the rapidly evolving field of aging research.
Our mission is to advance the science and application of cellular senescence therapeutics by bringing together leading experts across academia, biotechnology, pharmaceuticals, investment, and regulatory sectors. This highly curated and professional forum is designed to promote innovation, facilitate partnerships, and drive translational breakthroughs in therapies targeting age-related diseases.
The Summit is structured to encourage idea exchange, interdisciplinary collaboration, and coordinated efforts, ensuring that discoveries in senescence biology can translate into meaningful therapeutic advancements. By uniting scientific, clinical, and business stakeholders, we aim toaccelerate the development of life-changing interventions that address the growing burden of chronic degenerative diseases in aging populations.
Featuring Academic talks by:
Daohong Zhou, Professor of Department of Biochemistry and Structure Biology Direct of the Center for Innovative Drug Discovery Associate Direct for Drug Development of the Mays Cancer Center Joe R. & Teresa Lozano Long School of Medicine University of Texas Health Science Center at San Antonio
Andrea Alimonti, Director, Institute of Oncology Research ETH Professor of Experimental Oncology Università della Svizzera Italiana
Marissa Schafer, Associate Professor of Physiology Director of the Brain and Systemic Aging Laboratory Aging Neurology Program Leader, Robert and Arelene Kogod Center on Aging Mayo Clinic
Featuring Industry talks by:
Frederick Beddingfield, Rubedo Life Sciences, CEO
Robin Mansukhani, Deciduous Therapeutics, CEO
Matthew Scholz, Oisin Bio, CEO
Anirvan Ghosh, CEO, Unity Biotechnology